Cargando…

Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study

Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Toussirot, Éric, Grandclément, Émilie, Gaugler, Béatrice, Michel, Fabrice, Wendling, Daniel, Saas, Philippe, Dumoulin, Gilles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861781/
https://www.ncbi.nlm.nih.gov/pubmed/24379815
http://dx.doi.org/10.3389/fimmu.2013.00453
_version_ 1782295685324865536
author Toussirot, Éric
Grandclément, Émilie
Gaugler, Béatrice
Michel, Fabrice
Wendling, Daniel
Saas, Philippe
Dumoulin, Gilles
author_facet Toussirot, Éric
Grandclément, Émilie
Gaugler, Béatrice
Michel, Fabrice
Wendling, Daniel
Saas, Philippe
Dumoulin, Gilles
author_sort Toussirot, Éric
collection PubMed
description Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory/immune response. RA and AS are both associated with the development of cardiovascular complications. It is has been established that central/abdominal, and particularly intra-abdominal or visceral adiposity is closely linked to cardiovascular events. Thus, in this study, we aimed to evaluate the body composition of patients with RA or AS compared to healthy controls (HC), with a special emphasis on the visceral region. In parallel, we measured adipose products or adipokines, namely leptin, adiponectin and its high molecular weight (HMW) isoform, resistin, and ghrelin, a gastric peptide that plays a role in energetic balance. The homeostasis model assessment for insulin resistance (HOMA-IR) and atherogenic index were used to evaluate cardiovascular risk. One hundred and twelve subjects were enrolled (30 patients with RA, 31 with AS, and 51 HC). Body composition was measured using dual-energy X-ray absorptiometry to determine total fat mass and lean mass, adiposity, fat in the android and gynoid regions, and visceral fat. Patients and HC did not differ in terms of body mass index. On the contrary, adiposity was increased in RA (p = 0.01) while visceral fat was also increased, but only in women (p = 0.01). Patients with AS tended to have lower total fat mass (p = 0.07) and higher lean mass compared to HC (p = 0.07). Leptin and leptin/fat mass were decreased in male patients with AS (p < 0.01), while total adiponectin and the ratio of HMW to total adiponectin were both increased in RA (p < 0.01). There were no changes in serum resistin and ghrelin in any group of patients. HOMA-IR and the atherogenic index were not modified in RA and AS. These results confirm that body composition was altered in RA and AS, affecting distinct soft tissue compartments. The effect of the increased visceral adipose tissue on cardiovascular risk is presumably attenuated by the favorable cardiometabolic profile in women with RA, as suggested by the normal HOMA-IR and atherogenic index.
format Online
Article
Text
id pubmed-3861781
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-38617812013-12-30 Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study Toussirot, Éric Grandclément, Émilie Gaugler, Béatrice Michel, Fabrice Wendling, Daniel Saas, Philippe Dumoulin, Gilles Front Immunol Immunology Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are inflammatory rheumatic diseases that may modify body composition. Adipose tissue has the ability to release a wide range of products involved in physiologic functions, but also in various pathological processes, including the inflammatory/immune response. RA and AS are both associated with the development of cardiovascular complications. It is has been established that central/abdominal, and particularly intra-abdominal or visceral adiposity is closely linked to cardiovascular events. Thus, in this study, we aimed to evaluate the body composition of patients with RA or AS compared to healthy controls (HC), with a special emphasis on the visceral region. In parallel, we measured adipose products or adipokines, namely leptin, adiponectin and its high molecular weight (HMW) isoform, resistin, and ghrelin, a gastric peptide that plays a role in energetic balance. The homeostasis model assessment for insulin resistance (HOMA-IR) and atherogenic index were used to evaluate cardiovascular risk. One hundred and twelve subjects were enrolled (30 patients with RA, 31 with AS, and 51 HC). Body composition was measured using dual-energy X-ray absorptiometry to determine total fat mass and lean mass, adiposity, fat in the android and gynoid regions, and visceral fat. Patients and HC did not differ in terms of body mass index. On the contrary, adiposity was increased in RA (p = 0.01) while visceral fat was also increased, but only in women (p = 0.01). Patients with AS tended to have lower total fat mass (p = 0.07) and higher lean mass compared to HC (p = 0.07). Leptin and leptin/fat mass were decreased in male patients with AS (p < 0.01), while total adiponectin and the ratio of HMW to total adiponectin were both increased in RA (p < 0.01). There were no changes in serum resistin and ghrelin in any group of patients. HOMA-IR and the atherogenic index were not modified in RA and AS. These results confirm that body composition was altered in RA and AS, affecting distinct soft tissue compartments. The effect of the increased visceral adipose tissue on cardiovascular risk is presumably attenuated by the favorable cardiometabolic profile in women with RA, as suggested by the normal HOMA-IR and atherogenic index. Frontiers Media S.A. 2013-12-13 /pmc/articles/PMC3861781/ /pubmed/24379815 http://dx.doi.org/10.3389/fimmu.2013.00453 Text en Copyright © 2013 Toussirot, Grandclément, Gaugler, Michel, Wendling, Saas, Dumoulin and CBT-506. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Toussirot, Éric
Grandclément, Émilie
Gaugler, Béatrice
Michel, Fabrice
Wendling, Daniel
Saas, Philippe
Dumoulin, Gilles
Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title_full Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title_fullStr Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title_full_unstemmed Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title_short Serum Adipokines and Adipose Tissue Distribution in Rheumatoid Arthritis and Ankylosing Spondylitis. A Comparative Study
title_sort serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. a comparative study
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861781/
https://www.ncbi.nlm.nih.gov/pubmed/24379815
http://dx.doi.org/10.3389/fimmu.2013.00453
work_keys_str_mv AT toussiroteric serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT grandclementemilie serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT gauglerbeatrice serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT michelfabrice serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT wendlingdaniel serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT saasphilippe serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT dumoulingilles serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy
AT serumadipokinesandadiposetissuedistributioninrheumatoidarthritisandankylosingspondylitisacomparativestudy